← Leaderboards
Hyungtae Kim
University Of Wisconsin-Madison
$120,980
Attributed
$120,980
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $45.5K · FY2019–21$50K$37.5K$25K$12.5K$0
'19
'20
'21
Funding mix
By agency
NIH$120,980 · 1
By mechanism
F31$120,980 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Wisconsin-Madison
Same institution · by research overlap
- Barak Blum$4,485,456
- Dawn B Davis$2,717,965
- Feyza Engin$2,445,785
- Lianwang Guo$8,850,010
- Ciara Leydon$1,404,394
Others in their field
Other Emerging Leaders on “Agonist”
- Julie Ake · National Institute Of Allergy And Infectious Diseases$22,000,000
- Aaron Esser-Kahn · University Of Chicago$13,378,548
- Nikej Shah · Nirsum Laboratories, Inc.$12,506,430
- Xinhua Li · Nano Terra, Inc.$11,941,250
- James Dale Berry · Brigham And Women'S Hospital$9,298,517
- James N Campbell · Centrexion Therapeutics Corporation$8,662,635
Research focus
AgonistAmericasApoptosisApoptoticAttenuatedAutomobile DrivingBaseB Cell ProliferationBeta CellBiologyCareerCareer DevelopmentCckbr GeneCell DeathCell PhysiologyCellsCell SurvivalCell TypeCholecystokininCholecystokinin ReceptorClinically RelevantComplications Of Diabetes MellitusCoupledAdverse Effects
Grant awards (3)
Selective cholecystokinin receptor signaling in the pancreatic islet as therapeutic target against diabetogenic stress$30,444
F31 · FY2021 · DK · contact PI
Selective cholecystokinin receptor signaling in the pancreatic islet as therapeutic target against diabetogenic stress$45,520
F31 · FY2020 · DK · contact PI
Selective cholecystokinin receptor signaling in the pancreatic islet as therapeutic target against diabetogenic stress$45,016
F31 · FY2019 · DK · contact PI